]>
IRCT20150706023084N16 IRCT 2023-08-21 Parmoon Salamat Amin Pharmaceutical Company Anaheal plus supplement in contact dermatitis Assessment of the therapeutic effects of Anaheal plus supplement in patients with contact dermatitis 2023-08-23 anticipated 50 Complete https://irct.ir/trial/70862 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: For all patients (both test group and control group), we prescribe the standard treatment that is moisturizing. In addition to the standard treatment, the test group also receives Anahil Plus supplement twice a day. The control group will receive a placebo instead of a supplement. After a month, we will re-examine the factors of the involvement level, redness, inflammation and itching, Randomization description: After the diagnosis of the disease by the dermatologist, using the rand number site, each patient was assigned a number, Blinding description: This study is conducted in single blind way, so that the patients are not aware of the contents of the received packages that contain Bremelin and Curcumin or placebo. Conventionally, the packages containing supplement number one and the packages containing placebo number two. We attribute Using rand number, we determine whether to give medicine or placebo to each patient. 3 Irritant contact dermatitis. Intervention 1: Intervention group: including 25 patients who are diagnosed with contact dermatitis by a dermatologist and consume Anahil Plus supplement produced by the company (two tablets daily) plus moisturizer as a standard treatment for 30 days. The questionnaire form is filled at the beginning and after one month. Intervention 2: Control group:includes 25 patients who are diagnosed with contact dermatitis by a dermatologist and use standard moisturizer as a treatment for 30 days along with a placebo containing lactose. The relevant questionnaire is filled at the beginning and 30 days later. Yes - There is a plan to make this available What will be shared: Data are collected in the form of a questionnaire When: After the intervention To whom: Qualified persons Conditions: Used foe scientific advancement in the field under study Where to obtain: Clinical office of Islamic Azad University,Medical science of tehran, Faculty of pharmacy How to obtain: Request in writing by going through legal procedures. Comments:
public Maryam Shiehmorteza
No.99, Yakhckal street, DR Shariati Avenue
Tehran Iran (Islamic Republic of) 1916893813 +98 21 2264 0056 Shiehmorteza@iaups.ac.ir Islamic Azad University scientific Maryam Shiehmorteza
No.99, Yakhchal street, Dr Shariati Avenue
Tehran Iran (Islamic Republic of) 1916893813 +98 21 2264 0056 Shiehmorteza@iaups.ac.ir Islamic Azad University Iran (Islamic Republic of) Adult patients (over 12 years old) Patient with contact dermatitis 12 years no limit Both Allergy to pineapple, celery, carrot and fennel having hemophilia taking two anti-platelet drugs or one anti-platelet drug and an anticoagulant severe kidney failure (GFR<30) severe liver failure (Child pugh B, C) Pregnancy lactation L24.9 Irritant contact dermatitis, unspecified cause Treatment - Drugs Placebo Intervention group: including 25 patients who are diagnosed with contact dermatitis by a dermatologist and consume Anahil Plus supplement produced by the company (two tablets daily) plus moisturizer as a standard treatment for 30 days. The questionnaire form is filled at the beginning and after one month. Control group:includes 25 patients who are diagnosed with contact dermatitis by a dermatologist and use standard moisturizer as a treatment for 30 days along with a placebo containing lactose. The relevant questionnaire is filled at the beginning and 30 days later. The surface of the affected area. Timepoint: 30 days. Method of measurement: Measuring with a ruler. Redness. Timepoint: 30 days. Method of measurement: According to REEDA. Edema. Timepoint: 30 days. Method of measurement: According to REEDA. Itching. Timepoint: 30 days. Method of measurement: Ask the patient. Parmoon Salamat Amin Pharmaceutical Company Approved 2023-05-24 Ethics committee of Department of Pharmaceutical Sciences, Tehran Islamic Azad University of Medical Dr Shariati Ave., Gholhak, Yakhchal Ave., Islamic Azad University of Pharmaceutical Sciences Branch Tehran Tehran Iran (Islamic Republic of)